Maternal-Infant Research on Environmental Chemicals
- The primary objectives of the MIREC Study are:
- to determine whether current non-occupational exposure to heavy metals, such as lead (as measured in maternal and infant biospecimens), is related to elevated maternal blood pressure or fetal growth restriction and
- to obtain national-level contemporary biomarkers of in utero and lactational exposure to priority environmental chemicals (e.g. heavy metals, phthalates, brominated flame retardants, bisphenol A [BPA]).
Overview
- Acronym
- MIREC
- Website
- MIREC
- Investigators
-
- Contacts
-
General Design
- Study design
- Cohort
- Start - End Year
- 2008 -
- General Information on Follow Up (profile, frequency)
-
Participants were followed-up at each trimester of pregnancy, at delivery and at post-delivery time points (day 1-2, 2-10 weeks, 6 months, 15 months, 3 years, and 5 years post-partum).
- Recruitment Target
-
- Families
- Number of Participants
- 5,590
- Number of Participants with Biological Samples
- 3,942
- Supplementary information about number of participants
-
Mothers: 1983 participants
Fathers: 1648 participants
Children: 1959 participants
Final sample includes 1983 mothers who completed visit 1 (including 48 multiple pregnancies),1959 livebirths (including 98 babies from the 48 mothers), and 340 fathers.
Access
Availability of data and biosamples
Possible Access to Data | |
Possible Access to Biosamples | |
Other |
|
- On the study website : http://www.mirec-canada.ca
- By contacting the study representative: Biobank Manager Nicole Lupien (CHU Sainte-Justine)
Sector of research
Possible Access to Data | Possible Access to Biosamples | |
Investigators from the public sector | ||
Investigators from the private sector | ||
Investigators from not-for-profit organization |
Transfer
Possible Access to Data | Possible Access to Biosamples | |
Can leave the study facility | ||
Can leave the country |
The restriction is on individual-level data / biological samples can leave the country (choice of laboratory must be justified
Cost
Possible Access to Data | Variable Cost |
Possible Access to Biosamples | Variable Cost |
Cost estimate is provided after review of the preliminary application
Cost reduction for co-analyses
Possible Access to Data | |
Possible Access to Biosamples |
Cost is established based on multiple factors, on a case-by-case
Marker Paper
Arbuckle Tye E., Fraser William D., Fisher Mandy et al. Cohort profile: the maternal-infant research on environmental chemicals research platform. Paediatr Perinat Epidemiol. 2013 Jul;27(4):415-2
PUBMED 23772943Timeline
Populations
This population is composed of women aged 18 years and older and whom are less than 14 weeks pregnant, who were attending prenatal clinics.
Selection Criteria
- Gender
-
Women only
- Minimum age
-
18
- Pregnant Women
-
- First trimester
- Countries
-
- Canada
- Canadian Provinces
-
- Alberta
- British Columbia
- Manitoba
- Nova Scotia
- Ontario
- Quebec
- Territory
-
Vancouver, Edmonton, Winnipeg, Sudbury, Ottawa, Kingston, Hamilton, Toronto, Montreal and Halifax.
- Health Status
-
- Participants were excluded if they:
- had known fetal abnormalities (e.g. hydatidiform mole), or known fetal chromosomal or major malformations in the current pregnancy; and
- had a history of medical complications, including the following: renal disease with altered renal function; epilepsy; any collagen disease, such as lupus erythematosus and scleroderma; active and chronic liver disease (hepatitis); heart disease; serious pulmonary disease; cancer; haematological disorder (patient with anaemia or thombophilias will be included); threatened spontaneous abortion (women with previous bleeding in the first trimester were included if the site documented a viable fetus at the time of recruitment); and illicit drug use.
- Participants were excluded if they:
- Other Criteria
- Participants had to have the ability to consent and to communicate in English or French, be willing to provide a sample of cord blood and be planning on delivering at a local hospital.
Sources of Recruitment
- Specific Population
-
- Clinic patients
- Supplementary Information
-
Participants were recruited from the general population who were attending prenatal clinics (ultrasound, midwife and/or doctor's clinics) during the first trimester of pregnancy (6 to 14 weeks). Recruitment took place from 2008 to 2011.
Sample Size
- Number of Participants
- 1,983
- Number of Participants with Biological Samples
- 1,983
- Supplementary information about number of participants
-
Prenatal visit 1: 1983 participants
Prenatal visit 2: 1831 participants
Prenatal visit 3: 1733 participants
Delivery : 1727 participants
Postpartum visit 1 and 2 : 1385
Data Collection Events
# | Name | Data sources | Data sources - Biosamples | Start | End |
---|---|---|---|---|---|
0 | MIREC - Mothers - Prenatal Visit 1 |
|
|
2008 (February) | 2011 (March) |
1 | MIREC - Mothers - Prenatal Visit 2 |
|
|
2008 (May) | 2011 (June) |
2 | MIREC - Mothers - Prenatal Visit 3 |
|
|
2008 (July) | 2011 (September) |
3 | MIREC - Mothers - Delivery |
|
|
2008 (September) | 2011 (October) |
4 | MIREC - Mothers - Postpartum Visit 1 |
|
2008 (September) | 2011 (October) | |
5 | MIREC - Mothers - Postpartum Visit 2 |
|
|
2008 (October) | 2012 (April) |
7 | MIREC - Mothers - MIREC-ID 6 months |
|
2010 (August) | 2012 (May) | |
8 | MIREC - Mothers - MIREC-CD3 |
|
2012 (August) | 2014 (March) | |
9 | MIREC - Mothers - MIREC-CD Plus |
|
2013 (March) | 2015 (March) | |
10 | MIREC - Mothers - MIREC-ENDO |
|
|
2018 (January) | Ongoing |
The population is composed of the MIREC mothers’ newborn children (live births).
Selection Criteria
- Newborns
- Countries
-
- Canada
- Canadian Provinces
-
- Alberta
- British Columbia
- Manitoba
- Nova Scotia
- Ontario
- Quebec
- Territory
-
Vancouver, Edmonton, Winnipeg, Sudbury, Ottawa, Kingston, Hamilton, Toronto, Montreal and Halifax.
Sources of Recruitment
- Specific Population
-
- Other specific population : Children of the MIREC Study mothers
Sample Size
- Number of Participants
- 1,959
- Number of Participants with Biological Samples
- 1,959
- Supplementary information about number of participants
-
MIREC-Birth: 1959 participants
MIREC-ID 6months: 525 participants
MIREC-CD3: 370 participants
MIREC-CD Plus Biomonitoring: 803 participants
MIREC-CD Plus Neurodevelopment: 610 participants
Data Collection Events
# | Name | Data sources | Data sources - Biosamples | Start | End |
---|---|---|---|---|---|
0 | MIREC - Children - Birth |
|
|
2008 (September) | 2011 (October) |
1 | MIREC - Children - MIREC-ID Birth |
|
|
2010 (January) | 2011 (December) |
2 | MIREC - Children - MIREC-ID 6 months |
|
2010 (August) | 2012 (May) | |
3 | MIREC - Children - MIREC-CD3 |
|
2012 (August) | 2014 (March) | |
4 | MIREC - Children - MIREC-CD Plus Biomonitoring |
|
|
2013 (March) | 2015 (March) |
5 | MIREC – Children - MIREC-CD Plus Neurodevelopment |
|
|
2013 (April) | 2015 (March) |
6 | MIREC – Children - MIREC-ENDO |
|
|
2018 (January) | Ongoing |
The population is composed of the MIREC children’ fathers.
Selection Criteria
- Gender
-
Men only
- Countries
-
- Canada
- Canadian Provinces
-
- Alberta
- British Columbia
- Manitoba
- Nova Scotia
- Ontario
- Quebec
- Territory
-
Vancouver, Edmonton, Winnipeg, Sudbury, Ottawa, Kingston, Hamilton, Toronto, Montreal and Halifax.
Sources of Recruitment
- Specific Population
-
- Other specific population : Fathers of the MIREC Study children
Sample Size
- Number of Participants
- 1,648
Data Collection Events
# | Name | Data sources | Data sources - Biosamples | Start | End |
---|---|---|---|---|---|
0 | MIREC - Fathers - MIREC-ID Birth |
|
2010 (January) | 2011 (December) |
Participating Studies
Acronym | Name | Study design | Countries |
---|
Harmonization Initiatives Included
Acronym | Name |
---|
Datasets
Name | Data Collection Events | Variables |
---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
Areas of Information Collected per per Population and Data Collection Event
Networks
Acronym | Name | Harmonization Initiatives | Individual Studies |
---|